Fisetin has been proven to regulate the PI3K/AKT/mTOR, Wnt/β-catenin, NF-κB and TRAIL/TRAIL-R pathways to inhibit metastatic spread, autophagy, necroptosis and angiogenesis in different cancer types. Here, AKT1 is linked to cancer.